liquiritigenin has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, P; Fan, S; Geng, W; Li, C; Xiao, Q; Zhao, B; Zheng, J; Zhou, G | 1 |
| Baek, SY; Jang, EJ; Kim, KY; Kim, SC; Kim, YW; Ku, SK; Lee, EH; Lee, JH; Park, JY; Park, KI; Suk, HY | 1 |
2 other study(ies) available for liquiritigenin and Cirrhosis, Liver
| Article | Year |
|---|---|
Liquiritigenin suppresses the activation of hepatic stellate cells via targeting miR-181b/PTEN axis.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carbon Tetrachloride; Cell Proliferation; Down-Regulation; Flavanones; Glycyrrhiza; Hepatic Stellate Cells; Humans; Hydroxyproline; Immunohistochemistry; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred C57BL; MicroRNAs; PTEN Phosphohydrolase | 2020 |
Liquiritigenin inhibits hepatic fibrogenesis and TGF-β1/Smad with Hippo/YAP signal.
Topics: Adaptor Proteins, Signal Transducing; Animals; Carbon Tetrachloride; Cell Cycle Proteins; Cell Line; Flavanones; Hepatic Stellate Cells; Hippo Signaling Pathway; Humans; Liver Cirrhosis; Male; Mice, Inbred C57BL; Phosphorylation; Protective Agents; Protein Serine-Threonine Kinases; Signal Transduction; Smad Proteins; Transforming Growth Factor beta1; YAP-Signaling Proteins | 2019 |